Article
Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis
2019-11-14
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a relentless neurodegenerative syndrome of the human motor neuron system, for which no effective treatment exists. Variability in the rate of disease progression limits the efficacy of ALS clinical trials, suggesting that developing of better biomarkers for prognosis will facilitate therapeutic progress. Here, we applied unbiased next-generation sequencing to investigate the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ea661a94-bd87-524c-84f3-b9ab895b1479
- DOI
- 10.1101/833079